The Public Relations Committee under the Korea Pharmaceutical and Bio-Pharma Association held its regular general meeting on April 22 at the association’s office in Bangbae-dong, Seocho-gu, Seoul, and completed the election of a new chair and the formation of its executive team, the association said April 23.
The committee is a consultative body of public relations and external communications professionals from pharmaceutical and biotechnology companies.
Moon Jong-hoon, a director at Chong Kun Dang, was elected chair. Park Jae-hyeon, an executive director at Jeil Pharmaceutical, and Yoo Jeong-jae, a head at JW Pharmaceutical, were chosen as vice chairs. The secretariat will be led by Lee Jeong-seok, a director at SillaJen, and Jeon Ha-na, a team leader at Hugel.
Jeong Chan-ung, deputy head of the association, will serve as both secretary-general and auditor. The chair and other executive members will serve two-year terms.
The meeting also approved the 2025 financial settlement and the 2026 business plan as originally proposed.
Moon said he felt a “heavy sense of responsibility” in taking the post at what he called an important turning point for the pharmaceutical and biotechnology industry, and pledged to strengthen communication among member companies and expand information exchanges between the association and the media.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.